{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:58:47Z","timestamp":1791568727444,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2009,3,25]],"date-time":"2009-03-25T00:00:00Z","timestamp":1237939200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1007\/s00259-009-1115-z","type":"journal-article","created":{"date-parts":[[2009,3,24]],"date-time":"2009-03-24T06:38:04Z","timestamp":1237876684000},"page":"1407-1416","source":"Crossref","is-referenced-by-count":136,"title":["Peptide receptor radionuclide therapy with 90Y-DOTATOC in recurrent meningioma"],"prefix":"10.1007","volume":"36","author":[{"given":"Mirco","family":"Bartolomei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Bodei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta","family":"De Cicco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara Maria","family":"Grana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Cremonesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Botteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Melania","family":"Baio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demetrio","family":"Aric\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Sansovini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Paganelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,3,25]]},"reference":[{"key":"1115_CR1","first-page":"349","volume-title":"Cancer of the nervous system","author":"P Black","year":"1997","unstructured":"Black P. Meningiomas. In: Black P, Loeffler JS, editors. Cancer of the nervous system. Oxford UK: Blackwell Science; 1997. p. 349\u201362."},{"key":"1115_CR2","first-page":"449","volume-title":"Pathology of tumours of the nervous system","author":"D Russel","year":"1989","unstructured":"Russel D, Rubinstein L. Tumours of the meninges and related tissues. In: Russel D, Rubinstein L, editors. Pathology of tumours of the nervous system. Baltimore: Williams and Wilkins; 1989. p. 449\u2013532."},{"key":"1115_CR3","first-page":"22","volume-title":"Meningiomas","author":"J Rachlin","year":"1991","unstructured":"Rachlin J, Rosenblum M. Etiology and biology of meningiomas. In: Al-Mefty O, editor. Meningiomas. New York: Raven; 1991. p. 22\u201337."},{"key":"1115_CR4","first-page":"145","volume-title":"Meningiomas","author":"J Drake","year":"1991","unstructured":"Drake J, Hoffman H. Meningiomas in children. In: Al-Mefty O, editor. Meningiomas. New York: Raven; 1991. p. 145\u201352."},{"key":"1115_CR5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0090-3019(89)90048-7","volume":"31","author":"G Butti","year":"1989","unstructured":"Butti G, Assietti R, Casalone R, Paoletti P. Multiple meningiomas: a clinical, surgical and cytogenetic analysis. Surg Neurol 1989;31:255\u201360.","journal-title":"Surg Neurol"},{"key":"1115_CR6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0140-6736(74)92592-6","volume":"1","author":"B Modan","year":"1974","unstructured":"Modan B, Baidatz D, Mart H, Steinitz R, Levin SG. Radiation-induced head and neck tumours. Lancet 1974;1:277\u201379.","journal-title":"Lancet"},{"issue":"3","key":"1115_CR7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1159\/000120412","volume":"14","author":"C Balasubramaniam","year":"1988","unstructured":"Balasubramaniam C, Armstrong D, Cheek W, Laurent J. Postradiation meningiomas in a child. Pediatr Neurosci 1988;14(3):319\u201323.","journal-title":"Pediatr Neurosci"},{"key":"1115_CR8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1601-5223.1972.tb01017.x","volume":"71","author":"J Mark","year":"1972","unstructured":"Mark J, Levan G, Mitelman F. Identification by fluorescence of the G chromosome lost in human meningiomas. Hereditas 1972;71:163\u20138.","journal-title":"Hereditas"},{"issue":"2","key":"1115_CR9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF00273305","volume":"14","author":"H Zankl","year":"1972","unstructured":"Zankl H, Zang KD. Cytological and cytogenetical studies on brain tumors. 4. Identification of the missing G chromosome in human meningiomas as no. 22 by fluorescence technique. Humangenetik 1972;14(2):167\u20139.","journal-title":"Humangenetik"},{"issue":"3","key":"1115_CR10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/jnen\/61.3.215","volume":"61","author":"P Kleihues","year":"2002","unstructured":"Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 2002;61(3):215\u201329.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1115_CR11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/jnnp.20.1.22","volume":"20","author":"D Simpson","year":"1957","unstructured":"Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 1957;20:22\u201339.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1115_CR12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3171\/jns.1985.62.1.0018","volume":"62","author":"RO Marimanoff","year":"1985","unstructured":"Marimanoff RO, Dosoretz DE, Linggood RM, Ojemann RG, Martuzza RL. Meningioma: analysis of recurrence and progression after neurosurgical resection. J Neurosurg 1985;62:18\u201324.","journal-title":"J Neurosurg"},{"key":"1115_CR13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0090-3019(86)90233-8","volume":"25","author":"J Jaaskelainen","year":"1986","unstructured":"Jaaskelainen J, Haltia M, Servo A. Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome. Surg Neurol 1986;25:233\u201342.","journal-title":"Surg Neurol"},{"key":"1115_CR14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0360-3016(98)90008-6","volume":"15","author":"BW Taylor Jr","year":"1988","unstructured":"Taylor BW Jr, Marcus RB Jr, Friedman WA, Ballinger WE Jr, Million RR. The meningioma controversy: postoperative radiation therapy. Int J Radiat Oncol Biol Phys 1988;15:299\u2013304.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"1115_CR15","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0360-3016(97)00317-9","volume":"39","author":"KS Condra","year":"1997","unstructured":"Condra KS, Buatti JM, Mendenhall WM, Friedman WA, Marcus RB Jr, Rhoton AL. Benign meningiomas: primary treatment selection affects survival. Int J Radiat Oncol Biol Phys 1997;39(2):427\u201336.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"1115_CR16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00000421-198608000-00013","volume":"9","author":"JB Mesic","year":"1986","unstructured":"Mesic JB, Hanks GE, Doggett RL. The value of radiation therapy as an adjuvant to surgery in intracranial meningiomas. Am J Clin Oncol 1986;9(4):337\u201340.","journal-title":"Am J Clin Oncol"},{"issue":"2","key":"1115_CR17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1023\/A:1005853720926","volume":"37","author":"TW Dziuk","year":"1998","unstructured":"Dziuk TW, Woo S, Butler EB, Thornby J, Grossman R, Dennis WS, et al. Malignant meningioma: an indication for initial aggressive surgery and adjuvant radiotherapy. J Neurooncol 1998;37(2):177\u201388.","journal-title":"J Neurooncol"},{"key":"1115_CR18","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3171\/jns.1984.60.1.0052","volume":"60","author":"RC Chan","year":"1984","unstructured":"Chan RC, Thompson GB. Morbidity, mortality, and quality of life following surgery for intracranial meningiomas. A retrospective study in 257 cases. J Neurosurg 1984;60:52\u201360.","journal-title":"J Neurosurg"},{"key":"1115_CR19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3171\/jns.1994.80.2.0195","volume":"80","author":"BJ Goldsmith","year":"1994","unstructured":"Goldsmith BJ, Wara WM, Wilson CB, Larson DA. Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg 1994;80:195\u2013201. Erratum in: J Neurosurg 1994;80:777.","journal-title":"J Neurosurg"},{"issue":"10","key":"1115_CR20","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1586\/14737175.6.10.1447","volume":"6","author":"PY Wen","year":"2006","unstructured":"Wen PY, Drappatz J. Novel therapies for meningiomas. Expert Rev Neurother 2006;6(10):1447\u201364.","journal-title":"Expert Rev Neurother"},{"issue":"2","key":"1115_CR21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3171\/jns.2006.105.2.163","volume":"105","author":"S Pravdenkova","year":"2006","unstructured":"Pravdenkova S, Al-Mefty O, Sawyer J, Husain M. Progesterone and estrogen receptors: opposing prognostic indicators in meningiomas. J Neurosurg 2006;105(2):163\u201373.","journal-title":"J Neurosurg"},{"issue":"4","key":"1115_CR22","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1017\/S0317167100032960","volume":"24","author":"PM Black","year":"1997","unstructured":"Black PM. Hormones, radiosurgery and virtual reality: new aspects of meningioma management. Can J Neurol Sci 1997;24(4):302\u20136.","journal-title":"Can J Neurol Sci"},{"issue":"Suppl 1","key":"1115_CR23","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000201082","volume":"54","author":"JC Reubi","year":"1993","unstructured":"Reubi JC, Krenning EP, Lamberts SW, Kvols L. In vitro detection of receptors in human tumours. Digestion 1993;54(Suppl 1):76\u201383.","journal-title":"Digestion"},{"issue":"2","key":"1115_CR24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1053\/snuc.2002.31027","volume":"32","author":"M Jong De","year":"2002","unstructured":"De Jong M, Valkema R, Jamar F, Kvols LK, Kwekkeboom DJ, Breeman WA, et al. Somatostatin receptor-targeted radionuclide therapy of tumours: preclinical and clinical findings. Semin Nucl Med 2002;32(2):133\u201340.","journal-title":"Semin Nucl Med"},{"key":"1115_CR25","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1210\/jcem-63-2-433","volume":"63","author":"JC Reubi","year":"1986","unstructured":"Reubi JC, Maurer R, Klijn JG, Stefanko SZ, Foekens JA, Blaauw G, et al. High incidence of somatostatin receptors in human meningiomas: biochemical characterization. J Clin Endocrinol Metab 1986;63:433\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11 Suppl Intern","key":"1115_CR26","first-page":"132","volume":"28","author":"WW Herder de","year":"2005","unstructured":"de Herder WW, Kwekkeboom DJ, Valkema R, Feelders RA, van Aken MO, Lamberts SW, et al. Neuroendocrine tumors and somatostatin: imaging techniques. J Endocrinol Invest 2005;28(11 Suppl International):132\u20136.","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"1115_CR27","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/02841860701441848","volume":"46","author":"M Essen van","year":"2007","unstructured":"van Essen M, Krenning EP, De Jong M, Valkema R, Kwekkeboom DJ. Peptide receptor radionuclide therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours. Acta Oncol 2007;46(6):723\u201334.","journal-title":"Acta Oncol"},{"issue":"11","key":"1115_CR28","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1007\/s00259-006-0172-9","volume":"33","author":"JP Esser","year":"2006","unstructured":"Esser JP, Krenning EP, Teunissen JJ, Kooij PP, van Gameren AL, Bakker WH, et al. Comparison of [(177)Lu-DOTA(0),Tyr(3)]octreotate and [(177)Lu-DOTA(0),Tyr(3)]octreotide: which peptide is preferable for PRRT? Eur J Nucl Med Mol Imaging 2006;33(11):1346\u201351.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"1115_CR29","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1200\/JCO.2005.08.066","volume":"23","author":"DJ Kwekkeboom","year":"2005","unstructured":"Kwekkeboom DJ, Teunissen JJ, Bakker WH, Kooij PP, de Herder WW, Feelders RA, et al. Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors. J Clin Oncol 2005;23(12):2754\u201362.","journal-title":"J Clin Oncol"},{"issue":"7","key":"1115_CR30","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1007\/s00259-004-1571-4","volume":"31","author":"L Bodei","year":"2004","unstructured":"Bodei L, Cremonesi M, Grana C, Rocca P, Bartolomei M, Chinol M, et al. Receptor radionuclide therapy with 90Y-[DOTA]0-Tyr3-octreotide (90Y-DOTATOC) in neuroendocrine tumours. Eur J Nucl Med Mol Imaging 2004;31(7):1038\u201346.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"1115_CR31","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/bip.10349","volume":"66","author":"G Paganelli","year":"2002","unstructured":"Paganelli G, Bodei L, Handkiewicz Junak D, Rocca P, Papi S, Lopera Sierra M, et al. 90Y-DOTA-D-Phe1-Try3-octreotide in therapy of neuroendocrine malignancies. Biopolymers 2002;66(6):393\u20138.","journal-title":"Biopolymers"},{"issue":"4","key":"1115_CR32","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s002590100490","volume":"28","author":"G Paganelli","year":"2001","unstructured":"Paganelli G, Zoboli S, Cremonesi M, Bodei L, Ferrari M, Grana C, et al. Receptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotide. Eur J Nucl Med 2001;28(4):426\u201334.","journal-title":"Eur J Nucl Med"},{"issue":"1","key":"1115_CR33","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1089\/108497804773391694","volume":"19","author":"L Bodei","year":"2004","unstructured":"Bodei L, Handkiewicz-Junak D, Grana C, Mazzetta C, Rocca P, Bartolomei M, et al. Receptor radionuclide therapy with 90Y-DOTATOC in patients with medullary thyroid carcinomas. Cancer Biother Radiopharm 2004;19(1):65\u201371.","journal-title":"Cancer Biother Radiopharm"},{"issue":"2","key":"1115_CR34","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1053\/snuc.2002.31563","volume":"32","author":"M Chinol","year":"2002","unstructured":"Chinol M, Bodei L, Cremonesi M, Paganelli G. Receptor-mediated radiotherapy with 90Y-DOTA-DPhe1-Tyr3-octreotide: the experience of the European Institute of Oncology Group. Semin Nucl Med 2002;32(2):141\u20137.","journal-title":"Semin Nucl Med"},{"issue":"2","key":"1115_CR35","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00259-002-1023-y","volume":"30","author":"L Bodei","year":"2003","unstructured":"Bodei L, Cremonesi M, Zoboli S, Grana C, Bartolomei M, Rocca P, et al. Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study. Eur J Nucl Med Mol Imaging 2003;30(2):207\u201316.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1115_CR36","unstructured":"WHO handbook for reporting results of cancer treatment. Geneva, Switzerland: World Health Organization Offset Publication; 1979. p. 48."},{"key":"1115_CR37","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00944177","volume":"10","author":"S Green","year":"1992","unstructured":"Green S, Weiss GR. Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria. Invest New Drugs 1992;10:239\u201353.","journal-title":"Invest New Drugs"},{"issue":"6","key":"1115_CR38","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3171\/jns.1991.74.6.0861","volume":"74","author":"SM Grunberg","year":"1991","unstructured":"Grunberg SM, Weiss MH, Spitz IM, Ahmadi J, Sadun A, Russell CA, et al. Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone. J Neurosurg 1991;74(6):861\u20136.","journal-title":"J Neurosurg"},{"key":"1115_CR39","unstructured":"Grumberg SM, Rankin C, Townsend J, Ahmadi J, Feun L, Fredericks R, et al. Phase III double-blind randomized placebo controlled study of mifepristone (RU) for the treatment of unresectable meningioma. ASCO 2001 Proceedings 20:56a."},{"key":"1115_CR40","first-page":"1913","volume":"39","author":"S Klutmann","year":"1998","unstructured":"Klutmann S, Bohuslavizki KH, Brenner W, Behnke A, Tietje N, Kr\u00f6ger S, et al. Somatostatin receptor scintigraphy in postsurgical follow-up examinations of meningioma. J Nucl Med 1998;39:1913\u201317.","journal-title":"J Nucl Med"},{"issue":"5","key":"1115_CR41","first-page":"763","volume":"46","author":"M Henze","year":"2005","unstructured":"Henze M, Dimitrakopoulou-Strauss A, Milker-Zabel S, Schuhmacher J, Strauss LG, Doll J, et al. Characterization of 68Ga-DOTA-D-Phe1-Tyr3-octreotide kinetics in patients with meningiomas. J Nucl Med 2005;46(5):763\u20139.","journal-title":"J Nucl Med"},{"issue":"1 Suppl","key":"1115_CR42","first-page":"107","volume":"57","author":"E Gay","year":"2005","unstructured":"Gay E, Vuillez JP, Palombi O, Brard PY, Bessou P, Passagia JG. Intraoperative and postoperative gamma detection of somatostatin receptors in bone-invasive en plaque meningiomas. Neurosurgery 2005;57(1 Suppl):107\u201313.","journal-title":"Neurosurgery"},{"issue":"10","key":"1115_CR43","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1212\/01.wnl.0000271382.62776.b7","volume":"69","author":"MC Chamberlain","year":"2007","unstructured":"Chamberlain MC, Glantz MJ, Fadul CE. Recurrent meningioma: salvage therapy with long-acting somatostatin analogue. Neurology 2007;69(10):969\u201373.","journal-title":"Neurology"},{"issue":"3","key":"1115_CR44","first-page":"543","volume":"74","author":"JW Koper","year":"1992","unstructured":"Koper JW, Markstein R, Kohler C, Kwekkeboon DJ, Avezaat CJ, Lamberts SW, et al. Somatostatin inhibits the activity of adenylate cyclase in cultured human meningioma cells and stimulates their growth. J Clin Endocrinol Metab 1992;74(3):543\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1115_CR45","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jocn.2006.05.005","volume":"14","author":"KW Ko","year":"2007","unstructured":"Ko KW, Nam DH, Kong DS, Lee JI, Park K, Kim JH. Relationship between malignant subtypes of meningioma and clinical outcome. J Clin Neurosci 2007;14(8):747\u201353.","journal-title":"J Clin Neurosci"},{"issue":"3","key":"1115_CR46","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1227\/01.NEU.0000170980.47582.A5","volume":"57","author":"A Modha","year":"2005","unstructured":"Modha A, Gutin PH. Diagnosis and treatment of atypical and anaplastic meningiomas: a review. Neurosurgery 2005;57(3):538\u201350.","journal-title":"Neurosurgery"},{"issue":"5","key":"1115_CR47","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/cncr.10351","volume":"94","author":"DM Ho","year":"2002","unstructured":"Ho DM, Hsu CY, Ting LT, Chiang H. Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma. Cancer 2002;94(5):1538\u201347.","journal-title":"Cancer"},{"issue":"5","key":"1115_CR48","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/s00259-006-0338-5","volume":"34","author":"B Brans","year":"2007","unstructured":"Brans B, Bodei L, Giammarile F, Linden O, Luster M, Oyen WJ, Tennvall J. Clinical radionuclide therapy dosimetry: the quest for the \"Holy Gray\". Eur J Nucl Med Mol Imaging 2007;34(5):772\u201386.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"1115_CR49","first-page":"1467","volume":"47","author":"M Cremonesi","year":"2006","unstructured":"Cremonesi M, Ferrari M, Bodei L, Tosi G, Paganelli G. Dosimetry in peptide radionuclide receptor therapy: a review. J Nucl Med 2006;47(9):1467\u201375.","journal-title":"J Nucl Med"},{"issue":"10","key":"1115_CR50","first-page":"1599","volume":"47","author":"M Essen van","year":"2006","unstructured":"van Essen M, Krenning EP, Kooij PP, Bakker WH, Feelders RA, de Herder WW, et al. Effects of therapy with [177Lu-DOTA0, Tyr3]octreotate in patients with paraganglioma, meningioma, small cell lung carcinoma, and melanoma. J Nucl Med 2006;47(10):1599\u2013606.","journal-title":"J Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-009-1115-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-009-1115-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-009-1115-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T12:01:46Z","timestamp":1558699306000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-009-1115-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,25]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["1115"],"URL":"https:\/\/doi.org\/10.1007\/s00259-009-1115-z","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,25]]}}}